29
IAEA International Atomic Energy Agency Dicentric Assay Lecture Module 4

Dicentric Assay

  • Upload
    micol

  • View
    53

  • Download
    0

Embed Size (px)

DESCRIPTION

Dicentric Assay. Lecture Module 4. Dose response curves (1). 250 kVp X-rays. Neutron mean energies, MeV. 2.0. 0.7. 7.6. 14.7. 1 Gy min -1. 1.5. Dicentrics per cell. 0.5 Gy min -1. 1.0. 0.2 Gy h -1. 0.18 Gy h -1. 0.5. 60 Co g -rays. 0.0. 0. 1. 2. 3. 4. 5. Dose, Gy. - PowerPoint PPT Presentation

Citation preview

Page 1: Dicentric Assay

IAEAInternational Atomic Energy Agency

Dicentric Assay

LectureModule 4

Page 2: Dicentric Assay

IAEA15772

Dicentricsper cell

Dose, Gy0

2.0

1.5

1.0

0.5

0.03 41 2 5

Neutron meanenergies, MeV

0.7 7.6 14.7 250 kVp X-rays

60Co -rays

1 Gy min-1

0.5 Gy min-1

0.2 Gy h-1

0.18 Gy h-1

Dose response curves (1)

2

Page 3: Dicentric Assay

IAEA

Dose response curves (2)

Which radiations to use ?

3

Page 4: Dicentric Assay

IAEA

Dose response curves (3)

• Background control

• What doses to use ?

• How many data points ?

• How many cells to score ?

• How many donors to use?

Each lab should produce its own calibration curves; do not use other’s

4

Page 5: Dicentric Assay

IAEA

Cell culture (1)

• Need to score first metaphases (M1)

• 48h to complete first cell cycle

• Choose a medium that is not too fast growth

• Use PHA for mitogenic stimulation

• Monitor cell cycling with FPG staining

5

Page 6: Dicentric Assay

IAEA

Cell culture (2)

Two basic methods:

• Whole blood culture

• Separated lymphocyte culture

6

Page 7: Dicentric Assay

IAEA

Cell culture (3)

7

Page 8: Dicentric Assay

IAEA

Cell culture (4)

Fixation

This is a simple procedure

Basic steps:

• Harvest cells from culture

• Swell cells by hypotonic salt solution

• Fix cells in alcohol : acetic acid mixture

• Wash several times in fixative to remove non-metaphase cell debris

8

Page 9: Dicentric Assay

IAEA

Slide making

Essential points

• Clean, grease-free slides

• Cold, wet slides

• Laboratory ambient temperature and humidity

• Adjust concentration of metaphases

9

Page 10: Dicentric Assay

IAEA

Pre-treatment

Prior to staining

• Clean up the background cloudiness

• Brief wash in an RNAse A solution

– full protocol is given in the IAEA Manual

10

Page 11: Dicentric Assay

IAEA

Slide staining

Fluorescence plus Giemsa stain (FPG)

• Essential to ensure M1 scoring

Giemsa stain

• If confirmed that there are no M2 cells present

• If using early Colcemid culture method

11

Page 12: Dicentric Assay

IAEA

FPG Harlequin staining - an M2 cell

12

Page 13: Dicentric Assay

IAEA

Slide scoring

Two methods:

• Conventional by-eye

• Automated microscope assistance

13

Page 14: Dicentric Assay

IAEA

Scoring at the microscope

The old way The new way

14

Page 15: Dicentric Assay

IAEA

How many cells to score for overdose case ?

• Depends on dicentric frequency

• Depends on the statistical uncertainties needed

• Depends on urgency for result

• Depends on available skilled scorers

• Depends on availability of a metaphase finder

Essential points

15

Page 16: Dicentric Assay

IAEA

95% confidence limits on 500 or 1000 cells scored

Dose estimate Confidence No of cells scored

(mGy) limits 500 1000

100 Upper 320 245

Lower <0 16

250 Upper 448 380

Lower 111 141

500 Upper 677 627

Lower 333 383

1000 Upper 1178 1127

Lower 830 881

16

Page 17: Dicentric Assay

IAEA

Data recording (1)

The count of objects must balance

A metaphase with:

A dicentric plus its fragment still = 46

A centric ring plus its fragment = 47

Each excess acentric increases the count above 46 by +1

Tri-, quadri- centrics etc, are converted to dicentric equivalents

17

Page 18: Dicentric Assay

IAEA

Data recording (2)

Use a standard score sheet

• The sheet should include scorer and case ID

• Full retrieval of the observations on each cell

18

Page 19: Dicentric Assay

IAEA

Information storage

Securely preserve

• Data sheets

• Slides

• Surplus fixed cells

• Case file notes

19

Page 20: Dicentric Assay

IAEA

How to present the dose estimate (1)

• Read the dose off the appropriate dose response curve• This is easy

• Calculate the statistical uncertainties on the dose estimate• This is a little more difficult

• Report the result to the doctor or patient• This can be difficult: do they understand

statistics?

20

Page 21: Dicentric Assay

IAEA

How to present the dose estimate (2)

21

Page 22: Dicentric Assay

IAEA

How to present the dose estimate (3)

22

Page 23: Dicentric Assay

IAEA

How to present the dose estimate (4)

Which method to use?

In practice, in most cases the first and simpler

method is sufficient

23

Page 24: Dicentric Assay

IAEA

How to present the dose estimate (5)

• Does the ‘customer’ – understand what is a confidence limit?

• The biodosimetry laboratory has to be prepared to explain the result and put it into simple comprehensible terms. Not easy!

24

Page 25: Dicentric Assay

IAEA

How to present the dose estimate (6)

At low doses

• If the lower 95% confidence limit is negative it can be ignored and only the upper limit is of concern

• Consider presenting the result graphically as a probability distribution

25

Page 26: Dicentric Assay

IAEA

How to present the dose estimate (7)

26

Page 27: Dicentric Assay

IAEA

How to present the dose estimate (8)

Presenting the dose as an odds ratio

• This also applies to low, possibly zero, dose events

• It needs two sources of information:

A dose estimate from e.g., a badge

A dose estimate from dicentrics

• Which is correct?

27

Page 28: Dicentric Assay

IAEA

How to present the dose estimate (9)

Odds ratio

• Badge = 66 mSv

• Dicentrics = 1 in 1000 cells (background?)

• Dicentrics = zero dose with UCL = 100 mGy

• Consider 2 possibilities: zero or 66 mSv

• Odds ratio 4.5 : 1.0 in favour of zero dose

• Easy for a patient to understand

28

Page 29: Dicentric Assay

IAEA

Conclusions

This lecture has covered the dicentric assay from the aspects of:

• Producing dose response curves

• Processing the lymphocytes

• Making and scoring the slides

• Presenting the dose estimates in a way that can be understood by non-scientists

29